SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Northwest Biotherapeutics Inc.
An SI Board Since August 2006
Posts SubjectMarks Bans Symbol
760 18 0 NWBO
Emcee:  John McCarthy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
109Thanks John., it's amazing that they just applied in February to the Swiss..zeta1961-7/9/2007
108Hi Zeta - fwiw - I sure as hell did not see this coming. regards, JohnJohn McCarthy-7/9/2007
107John, did you hear a blood-curdling, side-splitting, mournful howl?..that's zeta1961-7/9/2007
106+3.90 +185% at that price market cap around $26 million Z - I hope you are stiJohn McCarthy-7/9/2007
105Northwest Biotherapeutics Gets Cancer Vaccine Approval 4:29 AM EDT July 9, 2007 RikRichter-7/9/2007
104citywire.co.ukRikRichter-7/9/2007
103I thought this was supposed to happen in September .... anyway -- sounds good toJohn McCarthy-7/9/2007
102NWBT Northwest Biotherapeutics Announces Effectiveness of Reverse Stock Split BRikRichter-6/22/2007
101Northwest Biotherapeutics Closes Its Placement of Shares With Foreign InstitutioRikRichter-6/22/2007
100Business Briefly From Herald staff and news services Published: Tuesday, June 19RikRichter-6/19/2007
99Northwest Biotherapeutics Prices Its Intended Placement of Shares with Foreign IRikRichter-6/18/2007
98I wonder what the precedent is for this move?...eomzeta1961-6/5/2007
97Northwest Biotherapeutics Files With FDA For Drug-Cost Recovery Dow Jones NewswiRikRichter-6/4/2007
96Northwest Biotherapeutics Initiates Its Intended Placement of Shares With ForeigRikRichter-6/4/2007
95Dendreon announces FDA confirms data required for Provenge licensure 9:00 AM EDTRikRichter-5/31/2007
94NWBT News Article: NW Biotherapeutics plans stock placement Puget Sound BusinesRikRichter-5/21/2007
93Interesting article on DNDN which has implications for NWBT: Dendreon Is Worth RikRichter-5/2/2007
92NWBT news article: Bothell biotech sees opportunity in Switzerland Northwest BRikRichter-4/20/2007
91John, I have no idea..I have seen 'blurbs' of such and such in Switzerlazeta1961-4/18/2007
90Hi Zeta ..... Please check out this NR and then would you noodle these questionJohn McCarthy-4/17/2007
89I really thought they did..you prolly saw some of my posts at the cancer thread.zeta1961-12/11/2006
88Hi Zeta bad, bad surprize ..... and yes, it underscores your point ... >&gJohn McCarthy-12/11/2006
87John, Neol's direct immune toxin candidate failed Message 23090430 Anotherzeta1961-12/11/2006
86Buy-out is the first that comes to mind..but you know that this part is out of mzeta1961-11/28/2006
85Hi Zeta I read it this morning and thought .... now HOW is this gonna happen? John McCarthy-11/28/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News